Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3)

Ann Intern Med. 2022 May;175(5):W55-W57. doi: 10.7326/M21-4810. Epub 2022 Mar 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives
  • Antiviral Agents / adverse effects
  • COVID-19 Drug Treatment*
  • Humans
  • Physicians*

Substances

  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Alanine